Related Experiment Videos

Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53:

M E Anderson1, B Woelker, M Reed

  • 1Department of Molecular Genetics and Microbiology, State University of New York, Stony Brook 11794-5222, USA.

Insights

The C-terminal domain of tumor suppressor p53 inhibits its sequence-specific DNA binding. Activators function by blocking this negative regulation, suggesting in vivo mechanisms are needed to release p53 for promoter binding.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • The tumor suppressor p53 protein plays a critical role in cellular responses to DNA damage.
  • p53 possesses two distinct DNA binding domains: a central sequence-specific domain and a C-terminal sequence-independent domain.

Purpose of the Study:

  • To investigate the regulatory role of the p53 C-terminal domain in sequence-specific DNA binding.
  • To elucidate the mechanisms by which p53's DNA binding activity is modulated.

Main Methods:

  • Studied the effect of large and small DNA binding on p53's central domain activity.
  • Assessed the impact of C-terminal deletion and various activator molecules on p53 DNA binding.
  • Investigated the interplay between p53 domains and DNA in vitro.

Main Results:

  • Binding of large DNA to the p53 C terminus negatively regulates sequence-specific DNA binding by the central domain.
  • Deletion of the C terminus enhances sequence-specific binding, particularly with large DNA.
  • Activator molecules (nucleic acid, antibody, peptide) promote p53 binding by overcoming C-terminal inhibition.

Conclusions:

  • The p53 C terminus acts as a negative regulator of sequence-specific DNA binding through interaction with large DNA.
  • Cellular mechanisms likely exist to counteract this C-terminal inhibition, enabling p53 to bind specific gene promoters in vivo.

Related Concept Videos